Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
---|
12/27/2006 | EP0638123B1 Bacterial nitroreductase for the reduction of cb 1954 and analogues thereof to a cytotoxic form |
12/27/2006 | CN1886422A A method of modulating cell survival, differentiation and/or synaptic plasticity |
12/27/2006 | CN1884516A Design and fermented production of recombinant peptide for reducing blood pressure |
12/27/2006 | CN1883710A Chemical modification method of antineoplastic oligopeptide and application thereof |
12/27/2006 | CN1291998C Ligand of NKG2D acceptor and use |
12/26/2006 | US7153945 Peptide, novel adsorbent, adsorption unit and adsorption method |
12/26/2006 | US7153936 A peptide of at least 5 amino acids containing a unique portion of a semaphorin, and such peptide has a semaphorin binding specificity |
12/26/2006 | US7153933 Solid phase method for synthesis peptide-spacer-lipid conjugates, conjugates synthesized thereby and targeted liposomes containing the same |
12/26/2006 | US7153931 Forms of membrane transport vector penetratin; a membrane translocation peptide carrier moiety of given amino acid sequence; use in the improved delivery of therapeutic agents into target cells |
12/26/2006 | US7153834 A homogeneous cyclosporin solution comprising a carrier dialkyl ester of aliphatic or aromatic dioic acid, hydrophilic lipophilic balance, forming emulsions in stomach with gastrointestinal fluids |
12/26/2006 | US7153490 Liposomes encapsulating anticancer drugs and use thereof in the treatment of malignant tumors |
12/21/2006 | WO2006133566A1 NOVEL Aß-BINDING PROTEIN AND ITS PEPTIDE DERIVATIVES AND USES THEREOF |
12/21/2006 | WO2006108686A3 Bnp agonists |
12/21/2006 | WO2006100430A3 Polypeptides |
12/21/2006 | WO2006097748A3 Peptide stabilizer compounds and screening method |
12/21/2006 | WO2006087533A3 Ricin-binding peptides and methods for use thereof |
12/21/2006 | WO2006050959A3 Molecules which promote hematopoiesis |
12/21/2006 | WO2005062967A3 Novel anti-il 13 antibodies and uses thereof |
12/21/2006 | US20060287500 Method for synthesis of C2-symmetric diamino diol mediated by titanium complexes |
12/21/2006 | US20060287432 Peptide purification by means of metal ion affinity chromatography |
12/21/2006 | US20060287306 Compounds to treat alzheimer's disease |
12/21/2006 | US20060287242 chemically modified peptides that not only stimulate insulin secretion in type II diabetics, but also produce other beneficial insulinotropic responses; in combination with antidiabetic agent, an anti-obesity agent, an anti-hypertensive agent, an anti-atherosclerotic agent and a lipid-lowering agent |
12/21/2006 | US20060287239 Biologically active peptides |
12/21/2006 | US20060287232 Granulysins; effective against Escherichia, Bacillus, and Salmonella |
12/21/2006 | US20060286632 Genetic engineered apolipoproteins has potent antioxidant activity on phospholipid surfaces; cardiovascular disorders, antiischemic agents, bone disorders, antiinflammatory agents |
12/21/2006 | DE102005027556A1 New Raf kinase inhibitor peptide useful in the preparation of medicament for the treatment of tumor |
12/21/2006 | CA2611836A1 Transmucosal delivery of peptide derivatives |
12/21/2006 | CA2611054A1 Novel a.beta.-binding protein and its peptide derivatives and uses thereof |
12/20/2006 | EP1734124A1 Prostate specific antigen peptides and uses thereof |
12/20/2006 | EP1734049A1 Tumour-associated peptides that bind to MHC-molecules |
12/20/2006 | EP1734048A1 Tumor-associated peptides that bind to MHC-molecules |
12/20/2006 | EP1733231A2 Peptides and peptidomimetics binding to cd23 |
12/20/2006 | EP1732596A2 Therapeutic use of rm1 antigen |
12/20/2006 | EP1732595A2 Identification of self and non-self antigens implicated in autoimmune diseases |
12/20/2006 | EP1732585A1 Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins |
12/20/2006 | EP1732581A2 Polypeptide transduction and fusogenic peptides |
12/20/2006 | EP1194164B1 Prion protein peptides and uses thereof |
12/20/2006 | CN1290857C Method for extracting and purifying microcytis toxin |
12/19/2006 | US7151088 Neuroprotective dietary supplement |
12/19/2006 | US7150869 Gene therapy; cytokine complex; anticancer agent |
12/14/2006 | WO2006133196A1 Modulation of cholesteryl ester transfer protein (cetp) activity |
12/14/2006 | WO2006132530A2 Methods and means for use in diagnostics and treatment of diabetes |
12/14/2006 | WO2006131564A2 Novel cysteine-depleted hydrophobin fusion proteins, their production and use thereof |
12/14/2006 | WO2006108586A3 Polymyxin b analogs for lps detoxification |
12/14/2006 | WO2006087550A8 Amyloid-binding peptides, analogues and uses thereof |
12/14/2006 | WO2006014552A3 Cyclic peptides for treatment of cachexia |
12/14/2006 | US20060281687 Cyclin groove inhibitors |
12/14/2006 | US20060281686 Aza-peptides |
12/14/2006 | US20060281685 biodrug as antitumor agents; hormone sensitive tumors; therapy for prostate gland or breast cancer |
12/14/2006 | US20060281684 Peptide dimer(s) whose structure is maintained by a pair of disulfide bonds between two cystein residues, which does not exceed 17 amino acids and has cationic and hydrophobic amino acid residues; noncovalently binds the lipopolysaccharide of Gramnegative bacteria with high affinity |
12/14/2006 | US20060281683 Branched cationic copolymers and methods for antimicrobial use |
12/14/2006 | US20060281671 Organic compounds |
12/14/2006 | US20060281130 Metod of modulation of interaction between receptor and ligand |
12/14/2006 | US20060280780 Antimicrobial polypeptides |
12/14/2006 | US20060280750 Anti-idiotypic antibodies which recognise the idiotope of an antibody specific for a yeast killer toxin possess microbicidal activity |
12/14/2006 | US20060280732 To suppress apoptotic pathways by inhibiting cytochrome c-mediated caspase activation; inhibit effects of apoptosis induced by oxidative stress, drugs, cytokines, Fas-ligand, alpha-fetoprotein, used to prevent apoptosis in culturing cells, in organ transplantation, in immunological autoimmune disorder |
12/14/2006 | CA2610976A1 Use of stefin a as a scaffold protein |
12/14/2006 | CA2609865A1 Modulation of cholesteryl ester transfer protein (cetp) activity |
12/13/2006 | EP1730192A2 Compositions and methods for detecting cyclic analogs of human parathyroid hormone (hpth) |
12/13/2006 | EP1730172A1 Methods and compositions for the treatment of gastrointestinal disorders |
12/13/2006 | EP1730171A1 Peptide mimotopes of mycobacterial mannosylated lipoglycans and uses thereof |
12/13/2006 | EP1730170A2 Method for inhibiting immune complex formation in a subjetc |
12/13/2006 | EP1730169A2 Metal-containing nanolayered composites, and applications thereof |
12/13/2006 | EP1730168A2 Functional method for generating or screening for ligands which modulate steroid hormone receptors |
12/13/2006 | EP1730110A1 Sulfur compounds as inhibitors of hepatitis c virus ns3 serine protease |
12/13/2006 | EP1729757A2 Inhibitors of dipeptidylpeptidase iv for regulating glucose metabolism |
12/13/2006 | EP1011704B1 Tumor necrosis factor receptor-derived peptide analogues |
12/13/2006 | CN1878789A Human cathelicidin antimicrobial peptides |
12/13/2006 | CN1876677A Novel lhrh antagonists, preparation method and pharmaceutical use thereof |
12/13/2006 | CN1876676A Antineoplastic oligopeptide and its preparation method and application |
12/13/2006 | CN1289521C Anagonism peptide of tumor necrosis factor and its application |
12/12/2006 | US7148404 Antimicrobial polypeptides |
12/12/2006 | US7148346 Feeding the feedstock into an extraction column under conditions adapted for separating more- or less-polar impurities from feedstock, lighter phase flows counter to a heavier phase; product is a cyclosporin, a rapamycin |
12/12/2006 | US7148322 Process for the preparation of echinocandin derivatives |
12/12/2006 | US7148197 Orally administered small peptides synergize statin activity |
12/12/2006 | US7148195 Antitumor agents; hormone sensitive tumors; therapy for prostate gland or breast cancer |
12/12/2006 | US7148193 Polypeptides for binding hormone receptors for detection of growth receptors for cattle or humans |
12/12/2006 | US7147858 Methods to improve immunogenicity of antigens and specificity of antibodies |
12/12/2006 | US7147838 Competitive binding with bombesin; radiopharmaceuticals for treatment of neoplastic diseases |
12/07/2006 | WO2006130718A2 Synthetic peptide inhibitors of thrombin |
12/07/2006 | WO2006130022A1 Modulation of ovulation by agonists and antagonists of bmprii |
12/07/2006 | WO2006129317A1 BACKBONE CYCLIZED MELANOCORTIN STIMULATING HORMONE (α S ) ANALOGS |
12/07/2006 | WO2006128951A1 Compositions for targeting amine oxidases in vivo |
12/07/2006 | WO2006128553A1 Binding partners of the placental growth factor, especially antibodies directed against the placental growth factor, production and use thereof |
12/07/2006 | WO2006128492A1 Artificial protein, method for absolute quantification of proteins and uses thereof |
12/07/2006 | WO2006128293A1 Kinin b1 receptor peptide agonists and uses thereof |
12/07/2006 | WO2006014559A3 Cyclic peptides for treatment of cachexia |
12/07/2006 | WO2005044992A3 Fusion initiation region in rna virus envelope proteins |
12/07/2006 | US20060277614 Mammal prolactin variants |
12/07/2006 | US20060276642 Compounds to treat Alzheimer's disease |
12/07/2006 | US20060276626 Methods for the production of peptide derivatives |
12/07/2006 | US20060276625 Compositions and methods for fusion protein separation |
12/07/2006 | US20060276622 Process for the determination of peptides corresponding to immunologically important epitopes and their use in a process for determination of antibodies or biotinylated peptides corresponding to immunologically important epitopes, a process for preparing them and compositions containing them |
12/07/2006 | US20060276621 Glycosylated specificity exchangers |
12/07/2006 | US20060276408 Thrombin inhibitors; protease inhibition, kinase inhibition, CAAX inhibition, interference with peptides binding to SH2 domains and inhibition of MCH-I and/or MHC II presentation of peptides to T cell receptors |
12/07/2006 | US20060276403 Agonist polypeptide of receptor for ZOT and zonulin |
12/07/2006 | US20060276402 Synthetic peptide inhibitors of thrombin and thrombin activation of protease activated receptors 1 and 4 |
12/07/2006 | US20060276401 Polypeptides useful for appetite suppression |
12/07/2006 | US20060276400 Modulation of cholesteryl ester transfer protein (CETP) activity |
12/07/2006 | US20060276399 Peptide antagonists of zonulin and methods for use of the same |